Search Results 81-90 of 21271 for anti-TNF drugs

1. Mayo Clinic researchers to present study findings at American College of Gastroenterologists Annual Scientific Meeting

   "When we examined the risk for preeclampsia in those on anti-TNF therapy ... "We theorize that exposure to anti-TNF agents is a marker of more severe ...

2. A Study of Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... etanercept for the treatment of patients with psoriatic arthritis (PsA).

3. Infliximab (Intravenous Route) Description and Brand Names - Mayo Clinic

   Infliximab injection is used alone or together with other medicines (eg, methotrexate) to reduce the symptoms and prevent the progression of ...

4. A Study to Evaluate both the Efficacy and Safety Profile of CP-690,550 in Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   ... anti-TNF-alpha therapy. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

5. Alzheimer's: Medicines help manage symptoms and slow decline - Mayo Clinic

   FDA-approved medicines for treating symptoms · Goals for treating symptoms · Cholinesterase inhibitors · Memantine · Medicine for agitation · Anti-amyloid treatment.

6. A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors - Mayo Clinic

   18-80 years of age, inclusive · Moderately to severely active UC as determined by the Mayo Clinic Score assessment (MCS) · Naive to treatment with any anti-TNF ...

7. Anti-Inflammatory Drugs, Nonsteroidal (Ophthalmic Route) Description and Brand Names - Mayo Clinic

   Descriptions. Ophthalmic anti-inflammatory medicines are used in the eye to lessen problems that can occur during or after some kinds of eye surgery. Sometimes, ...

8. A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis - Mayo Clinic

   A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to ...

9. AMG 181 in Subjects with Moderate to Severe Crohn's Disease - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... A maximum of approximately 80% of subjects with any prior anti-TNF ...

10. Infliximab (Intravenous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...